ENGOT has decided on the establishment of an Advisory board, i.e. a panel of experts from all ENGOT groups, in order to offer the list of those experts to pharmaceutical companies for possible consultation regarding future clinical trials. I am pleased to announce that Prof. David Cibula, Prof. Pavel Dundr, Prof. Daniela Fischerová and Prof. Zoltán Novák represent our group in the newly established ENGOT Advisory board.